Shares of Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shot up 6.9% during mid-day trading on Monday . The stock traded as high as $0.76 and last traded at $0.76. 359,107 shares were traded during trading, a decline of 69% from the average session volume of 1,157,904 shares. The stock had previously closed at $0.71.
Elite Pharmaceuticals Price Performance
The business has a fifty day moving average price of $0.57 and a 200-day moving average price of $0.51. The company has a current ratio of 3.27, a quick ratio of 1.90 and a debt-to-equity ratio of 0.12.
Elite Pharmaceuticals (OTCMKTS:ELTP - Get Free Report) last released its quarterly earnings results on Monday, June 30th. The specialty pharmaceutical company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $32.00 million during the quarter. Elite Pharmaceuticals had a negative return on equity of 6.92% and a negative net margin of 25.70%.
About Elite Pharmaceuticals
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Featured Stories
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
